- Omalizumab2008 | Publication without faculty affiliation
- Omalizumab - therapeutic perspective in the treatment of severe asthma +12006 | Publication without faculty affiliation
- Diabetes mellitus and an inadequately controlled bronchial asthma2015 | First Faculty of Medicine
- Anti-IgE monoclonal antibody (omalizumab) in the therapy of bronchial asthma2005 | Publication without faculty affiliation
- Termination of systemic corticosteroid therapy of a patient with bronchial asthma on biologic therapy with omalizumab2020 | Third Faculty of Medicine
- The effect of complex treatment in a patient with severe cortico-dependent asthma bronchiale2017 | Faculty of Medicine in Pilsen
- Known and less known roles of IgE in the pathogenesis of allergic asthma2019 | Faculty of Medicine in Hradec Králové
- Monoclonal humanized antibody anti-IgE (omalizumab) in the treatment of allergic bronchial asthma +12002 | Faculty of Medicine in Pilsen
- Anti-IgE monoclonal antibody therapy for severe bronchial asthma and other allergic disease2019 | Second Faculty of Medicine
- Successful treatment of refractory status asthmaticus with omalizumab: a case report2021 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Treatment of severe cold contact urticaria with omalizumab: case reports2012 | Faculty of Medicine in Pilsen
- Treatment of chronic spontaneous urticaria2016 | First Faculty of Medicine
- Evolution of our view on the IgE molecule role in bronchial asthma and the clinical effect of its modulation by omalizumab: Where do we stand today?2020 | Faculty of Medicine in Hradec Králové
- Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting2013 | First Faculty of Medicine
- Real-world effectiveness and safety of omalizumab in patients with uncontrolled severe allergic asthma from the Czech Republic2019 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
- Small, Prospective, Observational, Pilot Study in Patients with Severe Asthma after Discontinuation of Omalizumab Treatment2018 | Faculty of Medicine in Hradec Králové
- Effect of individual allergen sensitization on omalizumab treatment outcomes in patients with severe allergic asthma determined using data from the Czech anti-IgE registry2020 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Serum periostin levels in asthma patients in relation to omalizumab therapy and presence of chronic rhinosinusitis with nasal polyps2020 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Urticaria2019 | Faculty of Medicine in Pilsen
- Anti-IgE antibodies and their therapeutic utilization +12009 | Publication without faculty affiliation
- Biological treatment of severe eosinophic asthma2019 | First Faculty of Medicine
- Severe asthma treatment: need for characterising patients2005 | First Faculty of Medicine
- Pediatric asthma: An unmet need for more effective, focused treatments2019 | Second Faculty of Medicine
- Komentář ke studii2019 | First Faculty of Medicine
- Benralizumab - drug profile and first clinical experience2019 | Faculty of Medicine in Hradec Králové
- Allergic manifestations of inborn errors of immunity and their impact on the diagnosis: A worldwide study2022 | Second Faculty of Medicine
- Účinek benralizumabu u typicky alergického asthma bronchiale2021 | First Faculty of Medicine